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I N this communication we will discuss three questions about orthotopic liver 
transplantation (liver replacement). First, 
what are the indications for hepatic trans-
plantation? Second, what have been the 
results? Third, what is the outlook for im-
proving these figures? 
Orthotopic liver transplantation is often 
difficult, mainly because of the liver pathol-
ogy that essentially always creates severe 
portal hypertension and extensive venous 
collaterals. Thus, removal of the native 
liver may be an extremely formidable 
undertaking. Revascularization of the graft 
is performed in as anatomically normal a 
way as possible: anastomosing the portal 
vein and hepatic artery end-to-end and 
reconstructing the vena cava above and 
below the liver (Fig. 1) . 
By far the most unsatisfactory aspect of 
this operation has been bilary duct recon-
struction. In most of our cases, we have 
anastomosed the gallbladder to the duode-
num after ligating the distal common duct. 
This method has real advantages under 
conditions of immunosuppression because 
it can be performed without stents and 
drains . However, there have been a num-
ber of lethal complications with these 
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cholecystoduodenostomies, a point to which 
we will return later. 
INDICATIONS FOR 
ORTHOTOPIC TRANSPLANTATION 
Hepatic Malignancy 
At the beginning, we thought that the 
ideal reason for liver replacement would 
be primary hepatic malignancies, including 
hepatoma. An example of the kind of ex-
tensive hepatoma we treated in the early 
trials is shown in Fig. 2. Our enthusiasm 
was quickly dampened by a repetitive expe-
rience which can be illustrated with a single 
case. 
In Fig. 3 is the chest X-ray of a 15-yr-old 
boy a few weeks after successful orthotopic 
liver transplantation for a gigantic hepa-
toma, by which time there was already a 
small pulmonary metastasis at 29 days. He 
died 143 days after operation with his 
lungs almost replaced by metastases. Dur-
ing the same interval, his new liver was 
similarly invaded as could be followed with 
serial scans (Fig. 4). 
With the destruction of his liver he be-
came secondarily jaundiced (Fig. 5) and 
finally died of combined hepatic and pul-
monary insufficiency. At autopsy, his lungs 
were a mass of tumor. The same was true 
of the transplanted liver to an extent that 
only a remnant of normal hepatic tissue 
remained. We have six other so-called suc-
cessful liver transplantations with subse-
quent widespread metastases and, in fact, 
three of our patients died at or beyond l-yr 
posttransplantation of this complication. 
It is too early to conclude once and for 
all that liver transplantation cannot be used 
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Fig . 1. Orthotopic liver transplantation : 
the recipient operation. In most recent cases, 
cholecystoduodenostomy has been per-
formed for biliary drainage as shown. C.a. , 
celiac axis; C.d. , common duct; G.B., gall-
bladder; H.a., hepatic artery; I.V.C., inferior 
vena cava; P.V., portal vein; 8 .m.a., superior 
mesenteric artery . (A) The kind of arterial 
anastomosis most commonly used. The 
homograft celiac axis or common hepatic 
artery is attached to the proper or common 
hepatic artery of the recipient. (B) Arterial 
reconstruction of two homograft arteries. 
The vessels are individually anastomosed to 
the branches of the recipient proper hepatic 
artery. (C) Anastomos is of the homograft 
aorta to the recipient aorta. The variation 
was used in a 16-mo-old recipient because 
of the double arterial supply to the trans-
planted liver. (With permission of Ann . 8urg . 
168392, 1968.) 
to treat hepatoma. This can also be illus-
trated by another case. Pictured in Fig. 6 
is the liver of a child with biliary atresia 
in which was found a small 2 em hepatoma 
as an incidental pathologic feature . The 
child has a perfect result without evidence 
of tumor recurrence more than 2 yr later. 
Long survival after liver replacement in 
patients with hepatoma has also been re-
ported by Caine, DaIoze, and Fortner. 1- 3 
Nevertheless , we personally would prefer 
not to do more hepatomas at this time 
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because of the very high incidence of 
metastases exceeding 80 % . 
It has seemed possible that the outlook 
might be less gloomy if the malignant 
tumor were some kind other than a hepa-
toma. For example, cholangiocarcinomas 
might provide a reasonable indication. Then 
there are the rare neoplasms, of which the 
gross specimen in Fig. 7 is an example, with 
widespread multifocal primaries. This liver 
was taken from a 52-yr-old man who had 
a hemangioendothelial sarcoma. The neo-
plasm usually kills within a few weeks by 
intraabdominal hemorrhage or the develop-
ment of hepatic insufficiency rather than 
by spread. In the summer of 1971, we 
treated the patient with orthotopic liver 
transplantation. The histopathologic char-
acter of the growth showed nearly normal 
hepatic cells and malignant Kupffer cells. 
Postoperatively, the bilirubin fell from 
40 to nearly normal along with an improve-
ment in other liver functions (Fig. 8) . The 
patient survived a severe rejection which 
was eventually completely reversed. After 
achieving nearly normal function for more 
than 3 mo, this patient also developed wide-
spread pulmonary metastases, as well as 
extensive recurrence in his liver graft. Thus, 
here is one more example of the futility of 
treating hepatic malignancy with hepatic 
transplantation. 
In this last case, one of the immunosup-
pressive agents used was cyclophosphamide 
rather than azathioprine (Fig. 8). Cyclo-
phosphamide is, itself, one of the most 
widely used of the anticancer chemothera-
peutic drugs. It is also one of the best 
immunosuppressants. In addition, hetero-
logous ALG and prednisone were used. 
Benign Hepatic Disease 
Beginning in such a negative way about 
the indications for liver replacement is one 
way of indicating that the important future 
of hepatic transplantation is in the treat-
ment of nonneoplastic hepatic disease. 
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Fig. 2. The hepatoma and remaining liver excised from a 29-yr-old woman at the time of 
orthotopic transplantation. The operative specimen weighed 10 kg. (With permission. 5 ) 
There is little point in listing these dis-
eases since the end-stage is much the same 
in all. In fact, our general position now is 
that anyone under age 40 who is not a 
sociopath and who is dying of hepatic in-
sufficiency should theoretically be a candi-
date for liver transplantation. The most 
common diagnoses would, of course, be 
cirrhosis, chronic aggressive hepatitis, and 
biliary atresia. 
To date, the longest survivor in the 
world after liver transplantation was a boy 
whose operation was in July 1968, for bil-
iary atresia. His early course is shown in 
Fig. 9. There was a very minimal rejection 
crisis in the second postoperative month. 
His liver was biopsied at 3 yr and found 
to be almost normal. Then suddenly just 
before Christmas 1971, he developed mas-
sive liver necrosis and died of acute hepatic 
insufficiency a few days later after a total 
survival of 3.5 yr, of which almost all was 
spent in good health. 
The liver of another patient with benign 
disease is shown in Fig. 10. This child 
was suffering from Wilson's disease, which 
led to cirrhosis and finally profound liver 
failure. After operation, he had a grave 
rejection crisis (Fig. 11) which eventually 
reversed with an ultimately good result now 
after almost 3 yr. He has returned to his 
home in Ohio where he now goes to school. 
Wilson's disease is an inborn error of 
metabolism of which the precise patho-
Fig . 3. The extremely rapid development of pulmonary metastases in a patient whose indication for liver replacement was 
hepatoma. (A) The chest is clear 6 days after transplantation. (8) Twenty-nine days postoperative. Two metastases are visible in the 
lower left lung field (arrows). (C) Five days later the tumor deposits previously seen have grown in size (horizontal arrows) and a 
third focus is now present in the right upper lobe (vertical arrow). (0) Forty-four days; only 10 days have elapsed since the last 
examination . Metastatic growths are scattered throughout the lungs (arrows) . (E) Seventy-four days postoperative. (F) Four months 
after operation; transient dyspnea was first noticed a few days later. The patient died of pulmonary insufficiency 143 days after 
transplantation. (With permission.S) 
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Fig. 4. Destruction of a hepatic homograft by tumor recurrence, as demonstrated by 
serial technetium liver scans. (A) Sixty-eight days: the scan appears normal. (B) Ninety-
four days : the patient had become jaundiced. Hepatomegaly is evident.( C) One hundred one 
days : multiple areas of poor isotope concentration are now visible. (D) One hundred eleven 
days: the process has continued its rapid progression. By the time of death 1 mo later, 
the homograft was almost completely replaced by tumor. (With permission.5 ) 
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Fig. 5. The manifestations of the invasion 
and nearly complete destruction of an ortho-
topic liver homograft by recurrent hepatoma. 
The sporadic large doses of intravenous 
prednisolone were given because of the pos-
sibility that the deteriorating liver function 
was due to delayed rejection. At autopsy 
almost all the transplanted hepatic tissue 
was replaced by tumor. The liver scans of 
this patient shown in Fig. 4 are indicated 
by the lettered arrows (A-D). The normal 
range for Bessey-Lowry (B-L) alkaline phos-
phatase units is 1-3. The normals for the 
SGOT and SGPT units at this age are 60-100 
and 5-35, respectively. (With permission.5 ) 
physiology has never been worked out. The 
essential biochemical finding is the deposi-
tion of copper in all tissues, including the 
liver and brain. The characteristic Kayser-
Fleischer rings by which the ophthalmolo-
gist can make the diagnosis are nothing 
more than copper accumulations in the 
cornea. The information we have about this 
case makes us believe that this copper 
Fig. 6. The liver removed from a child 
with biliary atresia at the time of orthotopic 
hepatic transplantation. Note the 2 cm hepa-
toma, an incidental finding in the specimen. 
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Fig. 7. Macroscopic appearance of the liver excised at the time of hepatic transplantation 
for the indication of hemangioendothelial sarcoma. 
accumulation is not recurring posttrans-
plantation and that, on the contrary, copper 
metabolism is probably remaining relatively 
normal. After operation, there was a mas-
sive cupriuresis which lasted for almost 6 
mo. (Fig. 12) . At this time, the liver was 
biopsied and then biopsies were repeated 
after 1.5 and 2.5 yr. On both occasions the 
liver copper content was normal. 
We treated another patient with Wilson's 
disease 15 mo ago. In this patient the main 
indication for proceeding was extremely 
severe neurologic involvement that was not 
controlled by penicillamine therapy. The 
immunosuppressive treatment was with 
cyclophosphamide (Cytoxan) instead of 
azathioprine (Imuran); in addition to the 
cyclophosphamide, horse ALG and predni-
sone were administered. Rejection probably 
never occurred in this patient. There was 
a marked deterioration of hepatic function 
in the second postoperative month at which 
time jaundice developed with rises in trans-
aminases. At the same time, he developed 
Australia antigenemia with prodigious in-
creases in his complement fixation titers . 
Immunosuppression was not intensified and 
he spontaneously recovered. The reason for 
mentioning this second point is that we 
now realize how many factors other than 
rejection can cause deterioration of hepatic 
homograft function. The most important 
of these nonimmunologic complications are 
serum hepatitis, such as demonstrated in 
Fig. 13, biliary duct obstruction, which we 
will return to later since it is a dreaded 
complication, and drug-induced hepato-
toxicity. 
This concludes our remarks about indi-
cations, which can be summarized with one 
sentence. We believe the situation is com-
pletely analogous to that in renal trans-
( 
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Fig. 8. The early course of a 52-yr-old male who had total liver replacement as treatment 
for a hemangioendothelial sarcoma. This rare liver tumor usually causes death from fulminat-
ing hepatic failure in a few weeks or months, but it does not commonly metastasize. After 
transplantation, there was a severe rejection crisis. The protracted thrombocytopenia post-
operatively is often noted after liver transplantation and is probably due to thrombocyte 
sequestration in the homograft. ALG, horse antilymphocyte globulin; SGOT, serum glutamic 
oxalacetic transaminase in international units; and ARROW-625 milligrams of methyl 
prednisolone intravenously. (With permission.6) 
plantation in which field benign disease is 
also the prime indication for treatment. 
CLINICAL RESULTS 
Between Spring 1963 and July 1967, 
seven attempts at orthotopic liver trans-
plantation were made in Denver. All failed, 
with death in 21 days or less. Our own 
experience, including these cases and all 
subsequent ones until a little more than 
1 yr ago, has consisted of 42 cases. Survival 
of 1 yr or more was obtained in 11 of 
these 42 recipients (26 % ). The record was 
not disgraceful since all these patients were 
doomed to early death, but it can certainly 
stand improvement. 
A year or more after transplantation, 
eight patients were lost for the reasons and 
at the times indicated in Table 1. The most 
common causes of late failure were car-
cinomatosis and chronic rejection, account-
ing for three deaths each after 1 yr. Serum 
hepatitis (chronic aggressive variety) 
caused two late deaths. 
The whole question of serum hepatitis in 
transplant patients is just beginning to 
unfold but it is already established that it 
is a potentially serious matter. Liver dis-
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Fig. 9. The early course of a 4-yr-old child who survived for 3.5 years after orthotopic 
liver transplantation for the indication of biliary atresia. Note the rejection episodes at 1 rno 
and 2.5 rno, which were easily controlled. (With perrnission.5) 
Fig. 10. The native liver 
of a child whose hepatic 
failure was caused by Wil-
son's disease. The recip-
ient's postoperative course 
Is shown in Fig. 11. 
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Fig. 11. Postoperative course of an 11-yr-old recipient of an orthotopic liver homograft 
for cirrhosis secondary to Wilson's disease. A severe rejection crisis beginning about 3 wk 
posttransplantation eventually reversed and hepatic function has been essentially normal 
since the sixth postoperative month. The patient remains in good health almost 3 yr after 
operation. 
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Fig. 12. Urinary excretion of copper after 
orthotopic liver transplantation for Wilson's 
disease. Following operation there was a 
massive cupriuresis lasting 6 mo. A sec-
ondary peak of copper excretion occurred 
in response to a 3-day test course of peni-
cillamine. (With permission, Lancet 1 :505, 
1971). 
ease and, specifically, hepatitis in renal 
transplant patients is a very common com-
plication, occurring in 10%-20% of all 
kidney recipients in our center. The inci-
dence of serum hepatitis in our liver pa-
tients is even higher, and one example of 
this has already been demonstrated (Fig. 
13). In view of these observations, is there 
any hope of treating lethal serum hepatitis 
with liver transplantation? We do not know 
the answer to the question. However, it is 
worth telling of an extraordinary patient 
whose reason for transplantation was 
chronic aggressive hepatitis, Australia-anti-
gen positive. She was in profound hepatic 
failure. 
Transplantation was carried out on Au-
gust 6, 1970. The Australia antigen became 
negative for almost 2 mo and then returned 
to positive at the same time as a clinical 
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Fig. 13. Triple drug therapy with cyclo-
phosphamide, prednisone and horse anti-
lymphocyte globulin (ALG) in a patient who 
had an orthotopic liver transplantation for 
Wilson's disease. Rejection has never been 
diagnosed postoperatively. The temporary 
deterioration in hepatic function in the sec-
ond postoperative month was accompanied 
by Australia antigenemia detected by the 
complement fixation (CF) technique and 
consequently was thought to be a manifesta-
tion of serum hepatitis. (With permission.6 ) 
bout of acute serum hepatitis (Fig. 14). 
She recovered from this but her Australia 
antigen has remained positive to the pres-
ent. A repeat biopsy 14 mo after trans-
plantation revealed recurrence of the 
chronic aggressive hepatitis in her trans-
planted liver. She died of a Nocardia infec-
tion on April 21, 1972. Her homograft was 
the site of advanced chronic aggressive 
hepatitis. Nevertheless, meaningful life was 
prolonged and, in view of this, the issue 
of whether more similar patients should be 
treated is perhaps more of a philosophical 
than a medical one. 
FUTURE PROSPECTS 
The third question posed at the outset 
concerned the prospects of improving the 
outlook after liver replacement, assuming 
that only reasonable candidates with non-
malignant disease are accepted. One of the 
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real weaknesses in this procedure is ineffec-
tive reconstruction of the biliary duct. 
With cholecystoduodenostomy, we have 
had obstruction at or near the junction of 
the common and cystic ducts. The nature 
of the lesion can be appreciated by the 
kind of operative cholangiogram that is 
performed with a Foley catheter inserted 
into the gallbladder (Fig. 15). The obstruc-
tion of the duct system shown in Fig. 15 
was corrected in two cases at reoperation 
but too late. All four of the patients with 
this lesion died. 
A crucial question in cases like that just 
described is the reason for obstruction at 
or near the cvstic duct. In four recent cases 
of this kind in which specimens became 
available for histopathologic examination, 
Dr. K. A. Porter of London has made some 
intriguing observations. He found that the 
extrahepatic ducts had ulcerations and 
edema even though there was little or no 
evidence of active rejection. The epithelial 
cells of these ducts were swollen and had 
intranuclear inclusions resembling those of 
cvtomegalovirus (CMV). Thus, the very 
real possibilitv has to be kept open that this 
varietv of biliary duct obstruction has an 
infectious etiology. 
Whatever its cause, it is possible that 
this kind of biliary obstruction could be 
Table 1. Eleven One-Year Survivors After 
Orthotopic Transplantation 
Alive 3/11 :1-1/6-2-5/6 yr 
Died 8/11 :1-3'/2 yr 
12 mo: Cancer" 
12 mo: Serum hepatitis, liver failure 
14 mo: Cancer 
15 mo: Cancer 
15 mo: Rejection, liver failure 
20 mo: Nocardia infection, systemict 
30 mo: Rejection, liver failure 
42 mo: ? Rejection, liver failure 
"This patient actually died a few days short of 
one year. 
tThe homograft had not failed but had ad-
vanced chronic aggressive hepatitis, just as in her 
previously removed native kidney. 
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Fig. 14. Orthotopic hepatic transplantation for liver failure caused by chronic aggressive 
hepatitis. The Australia antigen, which had been detectable in multiple serum samples for 
1 yr before operation, disappeared within hours after removal of her own liver. However, the 
Au antigen reappeared in her blood stream about 2 mo posttransplantation at a time when 
she developed a clinical episode of hepatitis. 
avoided if the small caliber cystic duct were 
not made part of the conduit for bile drain-
age. In four recent cases of liver trans-
plantation, we have performed choledo-
choduodenostomy by the technique shown 
in Figs. 16 and 17 in which the common 
duct is passed through a short duodenal 
tunnel and then everted with a few sutures. 
Unfortunately, one of these patients died 
after disruption of the choledochoduode-
nostomy and the development of biliary 
peritonitis. As a consequence of this sad 
experience we have again reversed our-
selves and are inclined to perform chole-
cystoduodenostomy as a primary proce-
dure. However, we would promptly re-
explore with the slightest SuspICIOn of 
mechanical obstruction and then convert to 
the type of anastomosis shown in Figs. 16 
and 17 or to some other alternative re-
construction. 
In addition to improving the technical 
performance of liver transplantation, we 
believe it is important to try to use im-
munosuppressive agents that have low 
hepatotoxicity and with this objective we 
have switched since early last year to 
cycloph<;?sphamide instead of azathioprine 
for all our fresh cases. The usefulness of 
this major change will require much more 
evaluation before it can be generally rec-
ommended. However, we would like to tell 
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Cholecystoduodenostomy 
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Fig. 15. Cholangiography of a hepatic homograft. in which biliary reconstruction was with 
cholecystoduodenostomy. Left: Technique of dye injection through a duodenotomy and 
the anastomosis. Right: Obstructed duct system. Despite reexplorat ion and conversion to 
choledochoduodenostomy, the recipient died of uncontrolled sepsis 46 days after 
transplantation. 
Fig. 16. Technique of choledochoduo-
denostomy. After opening the duodenum (A), 
a submucosal tunnel is created (B, C) 
through which the homograft common bile 
duct is passed (E). 
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Fig. 17: Choledochoduodenostomy (con-
tinued). The homograft bile duct is secured 
in place with four fine sutures (G, H, I) in 
such a way as to create an everting nipple 
(J). 
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you now that our primary treatment in the 
next cases will be with cyclophosphamide, 
prednisone and, ALG. After 3-8 wk, we 
will then switch from cyclophosphamide to 
maintenance azathioprine. This switch-over 
technique has already had an extensive and 
highly satisfactory evaluation after human 
renal transplantation. 
SUMMARY 
A brief answer will now be given to 
each of the three questions posed at the 
beginning. First, the prime indication for 
liver replacement is nonneoplastic hepatic 
disease. Second, the l-yr survival in our 
clinic for all patients treated up to 1 yr ago 
was between 25% and 30%. Third, there 
should be considerable optimism that this 
survival can be improved by a better tech-
nical performance and especially by im-
proved biliary duct drainage. Some recent 
developments in immunosuppression in 
which cyclophosphamide has been used to 
replace or supplement azathioprine may 
also be beneficial. 
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